SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 3.823
EU - Europa 2.123
AS - Asia 2.013
SA - Sud America 398
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 8.409
Nazione #
US - Stati Uniti d'America 3.723
SG - Singapore 702
IT - Italia 450
CN - Cina 434
DE - Germania 341
RU - Federazione Russa 329
BR - Brasile 313
HK - Hong Kong 309
VN - Vietnam 299
SE - Svezia 279
IE - Irlanda 204
GB - Regno Unito 111
FR - Francia 107
CA - Canada 67
UA - Ucraina 65
IN - India 62
ID - Indonesia 45
AT - Austria 44
FI - Finlandia 37
DK - Danimarca 30
NL - Olanda 29
PL - Polonia 25
TR - Turchia 25
AR - Argentina 23
BD - Bangladesh 21
CO - Colombia 20
JP - Giappone 19
MX - Messico 19
ES - Italia 18
KR - Corea 18
ZA - Sudafrica 17
IQ - Iraq 15
EC - Ecuador 14
BE - Belgio 13
IR - Iran 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
PK - Pakistan 8
CL - Cile 7
LT - Lituania 7
PE - Perù 6
SA - Arabia Saudita 6
VE - Venezuela 6
CH - Svizzera 5
PY - Paraguay 5
UZ - Uzbekistan 5
BG - Bulgaria 4
EG - Egitto 4
EU - Europa 4
GR - Grecia 4
IL - Israele 4
PA - Panama 4
PH - Filippine 4
AZ - Azerbaigian 3
HN - Honduras 3
HU - Ungheria 3
MA - Marocco 3
NP - Nepal 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SY - Repubblica araba siriana 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.409
Città #
Ann Arbor 894
Singapore 416
Ashburn 330
Hong Kong 309
Frankfurt am Main 249
Chandler 244
Fairfield 225
Dublin 200
New York 154
Wilmington 150
Houston 114
Woodbridge 111
Milan 99
Beijing 89
Seattle 89
Ho Chi Minh City 86
Hanoi 80
Paris 79
Los Angeles 78
Dallas 75
Santa Clara 72
Cambridge 70
Princeton 70
Jacksonville 49
Hefei 46
Jakarta 43
Chicago 38
Altamura 37
Dearborn 36
Moscow 33
Buffalo 32
Lawrence 32
Vienna 32
Shanghai 30
São Paulo 28
The Dalles 24
Guangzhou 22
London 22
Pune 22
Nanjing 20
Rome 18
Seoul 18
Tokyo 18
Warsaw 18
Andover 17
Boardman 17
Fremont 17
Montreal 17
Nuremberg 17
Denver 16
Johannesburg 15
Poplar 15
Stockholm 15
Dong Ket 14
Munich 14
Bogotá 13
Helsinki 13
Ottawa 13
Boston 12
Brooklyn 12
Brussels 12
Lappeenranta 12
Phoenix 12
San Diego 12
Amsterdam 11
Changsha 10
Rio de Janeiro 10
Salt Lake City 10
Toronto 10
Council Bluffs 9
Haiphong 9
Lachine 9
Nairobi 9
Orem 9
Quận Bình Thạnh 9
Atlanta 8
Catania 8
Columbus 8
Da Nang 8
Falls Church 8
Hangzhou 8
Shenyang 8
Biên Hòa 7
Busto Arsizio 7
Chennai 7
Guarulhos 7
Hebei 7
Hải Dương 7
Kent 7
Lissone 7
Mexico City 7
Monza 7
Nanchang 7
Thái Nguyên 7
Brescia 6
Charlotte 6
Dhaka 6
Florence 6
Jinan 6
Manchester 6
Totale 5.467
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 447
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 329
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 304
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 303
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 278
HIV testing: A must for patients with inflammatory bowel disease 277
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 276
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 265
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 265
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 260
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 253
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 251
High rates of 30-day mortality in patients with cirrhosis and COVID-19 243
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 242
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 235
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 232
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 229
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 220
Unmasking tuberculosis in the era of antiretroviral treatment 212
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 209
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 208
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 208
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 191
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 186
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 181
Beware of biases in observational studies on anti-spike monoclonal antibodies 178
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 177
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 170
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 170
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 167
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis Service 147
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 139
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 132
Imported ciprofloxacin-resistant Neisseria meningitidis 132
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 128
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 127
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 127
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 116
Pharmacotherapy of HIV: Focus on Etravirine 105
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 92
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 78
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 74
Reply 48
Reply 46
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study 28
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 8.688
Categoria #
all - tutte 30.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021646 0 0 0 0 0 90 73 100 93 109 63 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.995 84 189 128 79 155 92 141 66 154 258 140 509
2025/20262.111 503 204 318 498 545 43 0 0 0 0 0 0
Totale 8.688